Grufity logo
Grufity logo
MLTX

MLTX - MoonLake Immunotherapeutics Stock Price, Fair Value and News

$18.38-0.33 (-1.76%)
Market Closed as of 29 Jul 2026, 04:00 pm ET

Price Targets

MLTX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MLTX Price Action

Last 7 days

-3.0%

Last 30 days

-7.7%

Last 90 days

12.2%

Trailing 12 Months

-64.9%

MLTX RSI Chart

MLTX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MLTX Valuation

Market Cap

1.4B

Price/Earnings (Trailing)

-5.25

EV/EBITDA

-5.69

Price/Free Cashflow

-6.04

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

MLTX Fundamentals

MLTX Earnings

Earnings (TTM)

-257.5M

Earnings Growth (Yr)

-74.51%

Earnings Growth (Qtr)

-12.41%

MLTX Profitability

Return on Equity

-101.37%

Return on Assets

-64.31%

Free Cashflow Yield

-16.57%

MLTX Investor Care

Shares Dilution (1Y)

16.42%

Diluted EPS (TTM)

-3.87

MLTX Alerts

  • 3 major insider sales recently.
Revenue & Growth

How MoonLake Immunotherapeutics generates revenue and covers its expenses, based on the latest reported earnings.

About MoonLake Immunotherapeutics

MLTX
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or axial spondyloarthritis. MoonLake Immunotherapeutics was incorporated in 2021 and is headquartered in Zug, Switzerland.
 CEO
 WEBSITEmoonlaketx.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES20

MoonLake Immunotherapeutics Frequently Asked Questions

MLTX is the stock ticker symbol of MoonLake Immunotherapeutics. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jul 29 2026, market cap of MoonLake Immunotherapeutics is 1.35 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.